PT - JOURNAL ARTICLE AU - Weber, César Augusto Trinta AU - Monteiro, Ingridi Teixeira AU - Gehrke, Julia Medeiros AU - de Souza, Wagner Silva TI - The Use of Psychoactive Substances in the Context of the Covid-19 Pandemic in Brazil AID - 10.1101/2020.09.25.20194431 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.25.20194431 4099 - http://medrxiv.org/content/early/2020/09/27/2020.09.25.20194431.short 4100 - http://medrxiv.org/content/early/2020/09/27/2020.09.25.20194431.full AB - Background The protocols for mitigating the transmission of Covid-19 seem to be a trigger for the use of psychoactive substances, as an individual’s adaptive response to support this new way of being in the world. Objective: To investigate the use of psychoactive substances in the context of the Covid-19 pandemic in Brazil. Method: A cross-sectional and prospective observational study, undertaken in a virtual environment. An online survey was developed and employed through Google Forms to collect data. The survey was made available to participants on social networks, Facebook@, Whatsapp@, and Instagram@, linked to the research group, during the period 06/15/2020 to 07/15/2020. 1,145 individuals participated in the research. Results: The average age of the participants was 37 years old. They were mostly female, white, Brazilians, with a higher education level, with occupations in the health field, and had religion. They either maintained their family income or suffered a small income decrease. Moreover, they informed that they were caring for social isolation. The most used substances before and after the beginning of the Covid-19 pandemic were alcohol, tobacco, marijuana, although the use of these substances decreased (P< 0.001). Approximately 32% of the participants started using psychoactive substances in this period. Among them, most individuals started by their own initiative. Conclusions: For a better understanding of the pattern use of psychoactive substances during the Covid-19 pandemic and the adverse effects on human behavior and mental disorders, careful longitudinal studies must be developed, due to the great interest in the knowledge of adaptive responses when people’s lives are at risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present study is in agreement with the recommendations of Resolution 466/2012, which provides ethical aspects in research with human beings in all phases. The research is registered at Plataforma Brasil/CONEP as CAAE 33505120.0.0000.5332. The research was approved according to the substantiated opinion number 4.086.949, by the Research Ethics Committee of Sao Pedro Psychiatric Hospital, Porto Alegre, RS.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.